About University of Kansas Cancer Center - North
The University of Kansas Medical Center, commonly referred to as KU Med or KUMC, is a medical campus for the University of Kansas. KU Med houses the university's schools of medicine, nursing, and health professions, with the primary health science campus in Kansas City, Kansas.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
78
SWOG Cancer Research Network
38
NRG Oncology
17
Alliance for Clinical Trials in Oncology
16
Radiation Therapy Oncology Group
12
University of Kansas Medical Center
9
ECOG-ACRIN Cancer Research Group
6
NSABP Foundation Inc
3
Qamar Khan
3
Priyanka Sharma
2
Anup Kasi
1
Clinical Trials at University of Kansas Cancer Center - North
During the past decade, University of Kansas Cancer Center - North conducted 119 clinical trials. In the 10-year time frame, 119 clinical trials started and 63 clinical trials were completed, i.e. on
average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 41 clinical trials were completed. i.e. 132.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
2005-12-01
2022-05-20
Completed
612
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
2006-04-01
2022-12-22
Completed
1,116
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
2007-05-08
2030-10-01
Active, not recruiting
788
S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
2007-09-01
2017-06-01
Completed
406
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
2008-03-01
2016-12-01
Completed
554
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
2007-12-01
Active, not recruiting
427
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Kansas Cancer Center - North" #1 sponsor was "National Cancer Institute (NCI)" with 78 trials, followed by "SWOG Cancer Research Network" with 38 trials
sponsored, "NRG Oncology" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored and "Radiation Therapy Oncology Group"
with 16 trials sponsored. Other sponsors include 25 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Cancer Center - North"
#1 collaborator was "National Cancer Institute (NCI)" with 94 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 31 different institutions and companies that were
collaborators in the rest 36 trials.
Clinical Trials Conditions at University of Kansas Cancer Center - North
According to Clinical.Site data, the most researched conditions in "University of Kansas Cancer Center - North" are
"Breast Cancer" (10 trials), "Prostate Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "University of Kansas Cancer Center - North" in a lesser frequency.
Clinical Trials Intervention Types at University of Kansas Cancer Center - North
Most popular intervention types in "University of Kansas Cancer Center - North" are "Drug" (149 trials), "Other" (98 trials), "Biological" (66 trials), "Radiation" (63 trials) and "Procedure" (53 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Quality-of-Life Assessment" (41 trials), "Biospecimen Collection" (30 trials), "Computed Tomography" (28 trials) and "Questionnaire Administration" (25 trials). Other intervention names were less common.
Clinical Trials Genders at University of Kansas Cancer Center - North
The vast majority of trials in "University of Kansas Cancer Center - North" are
147 trials for "All" genders, 22 trials for "Female" genders and 22 trials for "Male" genders.
Clinical Trials Status at University of Kansas Cancer Center - North
Currently, there are NaN active trials in "University of Kansas Cancer Center - North".
undefined are not yet recruiting,
58 are recruiting,
95 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 30 completed trials in University of Kansas Cancer Center - North,
5 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of Kansas Cancer Center - North, 19 "Phase 1"
clinical trials were conducted, 104 "Phase 2" clinical
trials and 90 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".